Raily Aesthetic Medicine International (HKG:2135) expects a loss attributable to owners of about 8 million yuan for the six months ended June 30, compared with a loss of about 2 million yuan a year earlier, according to an Aug. 8 Hong Kong bourse filing.

Revenue for the period is forecast at about 85 million yuan, down from about 117 million yuan in the same period last year.

Interim results are expected by the end of August.